ZA9710643B - 5-cyclo indole compounds - Google Patents
5-cyclo indole compoundsInfo
- Publication number
- ZA9710643B ZA9710643B ZA9710643A ZA9710643A ZA9710643B ZA 9710643 B ZA9710643 B ZA 9710643B ZA 9710643 A ZA9710643 A ZA 9710643A ZA 9710643 A ZA9710643 A ZA 9710643A ZA 9710643 B ZA9710643 B ZA 9710643B
- Authority
- ZA
- South Africa
- Prior art keywords
- loweralkyl
- optionally substituted
- membered
- independently selected
- ht1d
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Structures Or Materials For Encapsulating Or Coating Semiconductor Devices Or Solid State Devices (AREA)
- Hybrid Cells (AREA)
- Devices For Indicating Variable Information By Combining Individual Elements (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75580596A | 1996-11-26 | 1996-11-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9710643B true ZA9710643B (en) | 1998-09-02 |
Family
ID=25040731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9710643A ZA9710643B (en) | 1996-11-26 | 1997-11-26 | 5-cyclo indole compounds |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0944595B1 (fr) |
JP (1) | JP2001504501A (fr) |
CN (1) | CN1289479C (fr) |
AT (1) | ATE251136T1 (fr) |
AU (1) | AU738668B2 (fr) |
CA (1) | CA2273328C (fr) |
DE (1) | DE69725337T2 (fr) |
ES (1) | ES2208955T3 (fr) |
HK (1) | HK1026689A1 (fr) |
TW (1) | TW432059B (fr) |
WO (1) | WO1998023587A1 (fr) |
ZA (1) | ZA9710643B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6100291A (en) * | 1998-03-16 | 2000-08-08 | Allelix Biopharmaceuticals Inc. | Pyrrolidine-indole compounds having 5-HT6 affinity |
US6251893B1 (en) * | 1998-06-15 | 2001-06-26 | Nps Allelix Corp. | Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity |
US6329390B1 (en) * | 1998-07-17 | 2001-12-11 | Nps Allelix Corp. | 5-Bicycloindole compounds |
US6562809B1 (en) * | 1998-09-18 | 2003-05-13 | Nps Allelix Corp. | 3-bicycloindole compounds |
AU779073B2 (en) * | 1998-12-23 | 2005-01-06 | Nps Allelix Corp. | Indole and indolizidine derivatives for the treatment of migraine |
EP1803720A1 (fr) * | 2000-12-22 | 2007-07-04 | Wyeth a Corporation of the State of Delaware | Composes Heterocyclylindazole et Azaindazole utilises en tant que ligands 5-Hydroxytryptamine-6 |
CA2432654A1 (fr) | 2000-12-22 | 2002-07-04 | Wyeth | Composes heterocyclylindazole et azaindazole utilises en tant que ligands 5-hydroxytryptamine-6 |
TW200418830A (en) | 2003-02-14 | 2004-10-01 | Wyeth Corp | Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
US8030257B2 (en) | 2005-05-13 | 2011-10-04 | Exxonmobil Research And Engineering Company | Catalytic antioxidants |
CN102936240A (zh) * | 2012-10-30 | 2013-02-20 | 浙江省医学科学院 | 一种(r)-5-取代-3-(n-苄氧羰基吡咯烷-2-基羰基)-1h-吲哚的合成方法 |
CN107698558B (zh) * | 2017-10-24 | 2019-04-02 | 温州大学 | 一种氮杂环硫化物的制备方法及其净化提纯方法 |
EP3717467A1 (fr) * | 2017-12-01 | 2020-10-07 | Taiwanj Pharmaceuticals Co., Ltd. | Composé hétérocyclique fusionné au benzène et son utilisation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3678805D1 (de) * | 1985-11-08 | 1991-05-23 | Glaxo Group Ltd | Indolderivate. |
GB9226537D0 (en) * | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
US5300645A (en) * | 1993-04-14 | 1994-04-05 | Eli Lilly And Company | Tetrahydro-pyrido-indole |
CN1121348A (zh) * | 1993-04-22 | 1996-04-24 | 辉瑞研究及发展公司 | 吲哚衍生物作为5-ht1类激动剂用于治疗周期性偏头痛 |
-
1997
- 1997-11-24 CA CA002273328A patent/CA2273328C/fr not_active Expired - Fee Related
- 1997-11-24 AU AU51122/98A patent/AU738668B2/en not_active Ceased
- 1997-11-24 EP EP97945687A patent/EP0944595B1/fr not_active Expired - Lifetime
- 1997-11-24 DE DE69725337T patent/DE69725337T2/de not_active Expired - Fee Related
- 1997-11-24 JP JP52408398A patent/JP2001504501A/ja active Pending
- 1997-11-24 ES ES97945687T patent/ES2208955T3/es not_active Expired - Lifetime
- 1997-11-24 AT AT97945687T patent/ATE251136T1/de not_active IP Right Cessation
- 1997-11-24 CN CNB971815127A patent/CN1289479C/zh not_active Expired - Fee Related
- 1997-11-24 WO PCT/CA1997/000900 patent/WO1998023587A1/fr active IP Right Grant
- 1997-11-26 ZA ZA9710643A patent/ZA9710643B/xx unknown
- 1997-12-18 TW TW086119400A patent/TW432059B/zh not_active IP Right Cessation
-
2000
- 2000-03-29 HK HK00101951A patent/HK1026689A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69725337D1 (de) | 2003-11-06 |
AU738668B2 (en) | 2001-09-20 |
CA2273328A1 (fr) | 1998-06-04 |
AU5112298A (en) | 1998-06-22 |
CA2273328C (fr) | 2009-04-28 |
JP2001504501A (ja) | 2001-04-03 |
CN1289479C (zh) | 2006-12-13 |
WO1998023587A1 (fr) | 1998-06-04 |
EP0944595A1 (fr) | 1999-09-29 |
HK1026689A1 (en) | 2000-12-22 |
DE69725337T2 (de) | 2004-07-15 |
CN1245491A (zh) | 2000-02-23 |
EP0944595B1 (fr) | 2003-10-01 |
TW432059B (en) | 2001-05-01 |
ES2208955T3 (es) | 2004-06-16 |
ATE251136T1 (de) | 2003-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9710643B (en) | 5-cyclo indole compounds | |
BR0013427A (pt) | Compostos heteropolicìclicos e seus usos como antagonistas no receptor de glutamato metabotrópico | |
DK5389D0 (da) | Substituerede pyrroler, pyrazoler og triazoler, fremgangsmaader til deres fremstilling samt deres anvendelse som angiotensin ii-antagonister | |
AU640417B2 (en) | Substituted 5-((tetrazolyl)alkenyl)imidazoles | |
SE8503680D0 (sv) | Indolderivat | |
NO962539D0 (no) | 5-(2-imidazolinylamino)benzimidazol-derivater, deres fremstilling og deres anvendelse som -2-adreniceptor-agonister | |
DK441187A (da) | Alfa-alkyl-4-amino-3-quinolinmethanoler og 1-(4-aralkylamino-3-quinolinyl)alkanoner, deres fremstilling og anvendelse | |
ATE12042T1 (de) | Aminosaeurederivate und ihre therapeutische verwendung. | |
BR0114552A (pt) | N1- (benzenosulfonil) indóis 2-,3-,4-, 5- substituìdos e seu uso em terapia | |
NO904799L (no) | Substituerte n-(imidazolyl)alkylalanin-derivater. | |
ES8504697A1 (es) | Un procedimiento para preparar n-formil y n-hidroximetil-3-fenoxi-1-azetidincarboxamidas | |
PT1189923E (pt) | Derivados aromaticos e heterociclicos de fitosterois e/ ou fitostanois para utilizacao no tratamento ou prevencao de doenca cardiovascular | |
KR950002761A (ko) | 강박 반응 장애 치료제 제조용으로서의 n-(피리디닐)-1h-인돌-1-아민의 용도 | |
SE9201076D0 (sv) | The use of old drugs for the treatment of diabetes | |
CA2175352A1 (fr) | 3-aryl-4-alkyl et 4,5-dialkyl-4h-1,2,4-triazoles permettant d'ameliorer la memoire | |
DE69114404D1 (de) | 1-(Pyridinylalkyl)-1H-indole, -indoline und Analoge. | |
DK423186A (da) | Spiro-(benzofuran-2(3h),1`cycloheptan)-derivater, deres fremstilling og anvendelse samt mellemprodukt til fremstillingen | |
DK114386D0 (da) | Benzo(c)-1,5-naphthyridiner, fremgangsmaade og mellemprodukter til fremstilling deraf og deres anvendelse som laegemidler | |
NO932002L (no) | Nye tiosemikarbazonsyreestere | |
NO902556D0 (no) | 4,5,5a,6-tetrahydro-3h-isoksazol(5,4,3-kl)akridinderivater og fremgangsmaate for fremstilling derav. | |
ATE158792T1 (de) | 2, 3-dihydro-4(1h)-quinazolinone zu magen- darmtherapien | |
TH20772A (th) | อนุพันธ์(3-(4-เฟนิลเพทเพทอราซิน-1-อิล) โพรพิลอมิโน)-ไพริดีน,ไพริมิดีนและเบนซีน การใช้สารเห่านี้เป็นยาและการเตรียมสารเหล่านี้ |